Lang Wu to AIDS Vaccines
This is a "connection" page, showing publications Lang Wu has written about AIDS Vaccines.
Connection Strength
0.377
-
Liu L, Wan Y, Wu L, Sun J, Li H, Li H, Ma L, Shao Y. Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine. Retrovirology. 2010 Sep 01; 7:71.
Score: 0.092
-
Wan Y, Liu L, Wu L, Huang X, Ma L, Xu J. Deglycosylation or partial removal of HIV-1 CN54 gp140 V1/V2 domain enhances env-specific T cells. AIDS Res Hum Retroviruses. 2009 Jun; 25(6):607-17.
Score: 0.085
-
Wan Y, Wu L, Liu L, Xu J, Liu Y, Liu Y, Shao Y. Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines. Vaccine. 2007 Jun 21; 25(26):4949-59.
Score: 0.072
-
Wu L, Yang ZY, Xu L, Welcher B, Winfrey S, Shao Y, Mascola JR, Nabel GJ. Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope. Vaccine. 2006 Jun 05; 24(23):4995-5002.
Score: 0.068
-
Liu Y, Wu L, Zhou KM, Zhang XD, Hong KS, Shao YM. [Construction of replication-deficient recombinant adenovirus expressing gag-polDelta and gp140TM genes of human immunodeficiency virus in mice]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Jun; 18(2):150-3.
Score: 0.060